ROLIMUS 5MG TABLET contains Everolimus which belongs to the group of medicines called Anticancer agents. It is used to manage hormone receptor-positive advanced breast cancer in postmenopausal women, in whom other managements, advanced tumours called neuroendocrine tumours that originate from the stomach, bowels, lung or pancreas, advanced kidney cancer (advanced renal cell carcinoma), where other managements (VEGF-targeted therapy) have not helped stop your disease.
Before taking ROLIMUS 5MG TABLET, inform your doctor if you have or ever had liver problems, diabetes, need to receive a vaccine, high cholesterol, recent major surgery or unhealed wound, an infection, hepatitis B, and are about to receive radiation therapy. ROLIMUS 5MG TABLET is not recommended to use in children and adolescents (under 18 years of age). Consult your doctor before taking the medicine.
ROLIMUS 5MG TABLET should be used with caution in elder patients (65 years and above). ROLIMUS 5MG TABLET is generally not recommended for use among pregnant and breastfeeding women. The most common side effects of taking ROLIMUS 5MG TABLET are fever, cough, difficulty breathing, wheezing, swelling, feeling of heaviness or tightness, pain. Contact your doctor for advice if any of the symptoms worsen.
No content available
